News

CALL FOR PAPERS DECEMBER 2024

IJSAR going to launch new issue Volume 05, Issue 12, December 2024; Open Access; Peer Reviewed Journal; Fast Publication. Please feel free to contact us if you have any questions or comments send email to: editor@scienceijsar.com

IMPACT FACTOR: 6.673

Submission last date: 15th December 2024

A comprehensive review on role of Artificial Intelligence (AI) in drug discovery and drug development

×

Error message

  • Notice: Trying to access array offset on value of type int in element_children() (line 6609 of /home1/sciensrd/public_html/scienceijsar.com/includes/common.inc).
  • Notice: Trying to access array offset on value of type int in element_children() (line 6609 of /home1/sciensrd/public_html/scienceijsar.com/includes/common.inc).
  • Deprecated function: implode(): Passing glue string after array is deprecated. Swap the parameters in drupal_get_feeds() (line 394 of /home1/sciensrd/public_html/scienceijsar.com/includes/common.inc).
Author: 
Kehar Singh, Rajkiran, Pinki, Prerna, Surender Chauhan, Rajesh Poswal and Satbir Singh
Page No: 
7789-7796

The modeling of human behavior in connection to the intellectual processes involved in problem solving is known as artificial intelligence (AI). Human cognitive science reading, observation, planning, interpretation, reasoning, correction, speech recognition, linguistics, and other sources are examples of these mechanisms. Artificial Intelligence (AI) streamlines processes by enabling computers to learn from prior experiences, map efforts and actions to outcomes, detect faults and rectify them, adapt to new and random input values, and carry out human-like jobs with ease through comprehensive scenario analysis. By evaluating, filtering, sorting, forecasting, scoping, and figuring out massive data volumes to adhere to the finest implementation practices for generating an ideal solution, artificial intelligence (AI) streamlines work. As of 2019, the main uses of AI in the pharmaceutical industry include: drug discovery and development; drug-adherence and dosage; using AI to make sense of clinical data and produce better analytics; finding more reliable patients for clinical trials more quickly; introducing automated robot pharmacies to fill prescriptions and dispensing; and marketing, logistics, and supply chain. Above all, artificial intelligence has the potential to save lives by reducing expenses and developing novel, efficient treatments. Thus, biotech businesses ought to begin utilizing AI's benefits as soon as possible. Therefore, adopting AI and machine learning solutions will benefit the sector greatly. It can be effectively applied to build a robust, long-lasting pipeline of novel medications. We would be able to develop medications more quickly and more cheaply if we could harness the power of contemporary supercomputers and machine learning. This paper provides a thorough analysis of the state of artificial intelligence in pharmaceutical sciences, with a focus on the pharmaceutical industry. In summary, human-machine cooperation is the way of the future, and as technology develops, human clinical professionals will also need to adapt, learn, and develop. It is the evolution of medicine, not its extinction, even though future experts will need to be proficient in both medicine and technology.

Download PDF: